P3 Health Partners Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $385M | ↑+3.8% | — | — | — |
| 2025-09-30 | $345M | ↓-4.7% | $-32M | ↑+32.1% | -12.8% |
| 2025-06-30 | $356M | ↓-6.2% | $-20M | ↓-69.4% | -9.6% |
| 2025-03-31 | $373M | ↓-3.9% | $-20M | ↓-9.5% | -10.2% |
| 2024-12-31 | $371M | ↑+6.9% | — | — | — |
| 2024-09-30 | $362M | ↑+25.6% | $-47M | ↓-249.8% | -29.5% |
| 2024-06-30 | $379M | ↑+15.2% | $-12M | ↓-22.5% | -8.3% |
| 2024-03-31 | $388M | ↑+28.6% | $-19M | ↓-103.3% | -11.3% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$385M
↑+3.8% +$14M YoY
Net Income
$362M
↑+5.3% +$18M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Go deeper
PIII Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPIII Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics